Choon‐Kee Lee

1.3k total citations
19 papers, 939 citations indexed

About

Choon‐Kee Lee is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Choon‐Kee Lee has authored 19 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Hematology and 11 papers in Oncology. Recurrent topics in Choon‐Kee Lee's work include Multiple Myeloma Research and Treatments (13 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer Treatment and Pharmacology (5 papers). Choon‐Kee Lee is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Histone Deacetylase Inhibitors Research (5 papers) and Cancer Treatment and Pharmacology (5 papers). Choon‐Kee Lee collaborates with scholars based in United States, Netherlands and China. Choon‐Kee Lee's co-authors include Bart Barlogie, Guido Tricot, Maurizio Zangari, Athanasios Fassas, Bolin Liu, Shuiliang Wang, Elias Anaissie, Frits van Rhee, Xiaoping Huang and Firas Muwalla and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Choon‐Kee Lee

19 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Choon‐Kee Lee United States	13	598	541	454	113	86	19	939
Behnaz Parhami-Seren United States	18	470 0.8×	348 0.6×	81 0.2×	113 1.0×	114 1.3×	39	983
Calogero Vetro Italy	14	306 0.5×	225 0.4×	215 0.5×	98 0.9×	31 0.4×	60	675
Lisa Gallinaro Italy	16	396 0.7×	306 0.6×	84 0.2×	84 0.7×	30 0.3×	32	856
Brandon McMahon United States	10	186 0.3×	295 0.5×	128 0.3×	173 1.5×	59 0.7×	32	675
Anne‐Marie Stoppa France	19	1.2k 1.9×	756 1.4×	592 1.3×	141 1.2×	8 0.1×	54	1.4k
Claudia Crippa Italy	13	818 1.4×	735 1.4×	516 1.1×	76 0.7×	12 0.1×	50	981
Debjit Biswas United States	8	220 0.4×	179 0.3×	62 0.1×	132 1.2×	26 0.3×	12	777
Shivlal Pandey United States	4	913 1.5×	634 1.2×	560 1.2×	130 1.2×	5 0.1×	6	1.0k
Adam Bryant Australia	12	180 0.3×	202 0.4×	69 0.2×	24 0.2×	27 0.3×	29	497
RM Stone United States	9	570 1.0×	282 0.5×	215 0.5×	123 1.1×	11 0.1×	13	940

Countries citing papers authored by Choon‐Kee Lee

Since Specialization

Citations

This map shows the geographic impact of Choon‐Kee Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Choon‐Kee Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Choon‐Kee Lee more than expected).

Fields of papers citing papers by Choon‐Kee Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Choon‐Kee Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Choon‐Kee Lee. The network helps show where Choon‐Kee Lee may publish in the future.

Co-authorship network of co-authors of Choon‐Kee Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Choon‐Kee Lee. A scholar is included among the top collaborators of Choon‐Kee Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Choon‐Kee Lee. Choon‐Kee Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wang, Shuiliang, Jingcao Huang, Hui Lyu, et al.. (2013). Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer. Breast Cancer Research. 15(5). R101–R101. 42 indexed citations

Cai, Bo, Shuiliang Wang, Jingcao Huang, et al.. (2013). Cladribine and bendamustine exhibit inhibitory activity in dexamethasone-sensitive and -resistant multiple myeloma cells.. PubMed. 5(1). 36–46. 11 indexed citations

Cai, Bo, Hui Lyu, Jingcao Huang, et al.. (2013). Combination of bendamustine and entinostat synergistically inhibits proliferation of multiple myeloma cells via induction of apoptosis and DNA damage response. Cancer Letters. 335(2). 343–350. 25 indexed citations

Cai, Bo, Jingcao Huang, Choon‐Kee Lee, & Bolin Liu. (2012). Abstract A49: Combination of bendamustine and the HDAC inhibitor entinostat enhances apoptosis and DNA damage response in multiple myeloma cells. Clinical Cancer Research. 18(10_Supplement). A49–A49. 1 indexed citations

Huang, Xiaoping, Shuiliang Wang, Choon‐Kee Lee, Xiaohe Yang, & Bolin Liu. (2011). HDAC inhibitor SNDX-275 enhances efficacy of trastuzumab in erbB2-overexpressing breast cancer cells and exhibits potential to overcome trastuzumab resistance. Cancer Letters. 307(1). 72–79. 36 indexed citations

Ma, Jian, Shuiliang Wang, Ming Zhao, et al.. (2011). Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma. BMC Cancer. 11(1). 255–255. 19 indexed citations

Lee, Choon‐Kee, Shuiliang Wang, Xiaoping Huang, John Ryder, & Bolin Liu. (2010). HDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cells. Cancer Letters. 296(2). 233–240. 45 indexed citations

Huang, Xiaoping, Li‐Zhi Gao, Shuiliang Wang, et al.. (2009). HDAC Inhibitor SNDX-275 Induces Apoptosis in erbB2-Overexpressing Breast Cancer Cells via Down-regulation of erbB3 Expression. Cancer Research. 69(21). 8403–8411. 56 indexed citations

Zangari, Maurizio, Dixie Esseltine, Choon‐Kee Lee, et al.. (2005). Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma. British Journal of Haematology. 131(1). 71–73. 146 indexed citations

10.

Zangari, Maurizio, Kevin B. Najarian, Dixie Esseltine, et al.. (2005). The Anti-Myeloma Effect of Bortezomib Is Associated with Osteoblastic Activity.. Blood. 106(11). 510–510. 2 indexed citations

11.

Zangari, Maurizio, Bart Barlogie, Elias Anaissie, et al.. (2004). Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation. British Journal of Haematology. 126(5). 715–721. 168 indexed citations

12.

Hollmig, Klaus, Giampaolo Talamo, Athanasios Fassas, et al.. (2004). Bortezomib (Velcade™) + Adriamycin™ + Thalidomide + Dexamethasone (VATD) as an Effective Regimen in Patients with Refractory or Relapsed Multiple Myeloma (MM).. Blood. 104(11). 2399–2399. 25 indexed citations

13.

Zangari, Maurizio, Bart Barlogie, Choon‐Kee Lee, et al.. (2004). Protective Effect of VELCADE® on Thalidomide-Associated Deep Vein Thrombosis (DVT).. Blood. 104(11). 4914–4914. 9 indexed citations

14.

Fassas, Athanasios, Bart Barlogie, Erik Rasmussen, et al.. (2004). Low Incidence of Complete Remission but Comparable Event-Free Survival(EFS) and Overall Survival (OS) with a History of Prior Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Myeloma (SMM) among Patients Receiving Total Therapy 2 (TT 2).. Blood. 104(11). 932–932. 2 indexed citations

15.

Zangari, Maurizio, Bart Barlogie, Klaus Hollmig, et al.. (2004). Marked Activity of Velcade Plus Thalidomide (V+T) in Advanced and Refractory Multiple Myeloma (MM).. Blood. 104(11). 1480–1480. 29 indexed citations

16.

Fassas, Athanasios, Bart Barlogie, Susan Ward, et al.. (2003). Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experience. British Journal of Haematology. 123(3). 484–489. 11 indexed citations

17.

Lee, Choon‐Kee, Bart Barlogie, Nikhil C. Munshi, et al.. (2003). DTPACE: An Effective, Novel Combination Chemotherapy With Thalidomide for Previously Treated Patients With Myeloma. Journal of Clinical Oncology. 21(14). 2732–2739. 133 indexed citations

18.

Anaissie, Elias, Shawna L. Stratton, María Cecilia Dignani, et al.. (2002). Cleaning Patient Shower Facilities: A Novel Approach to Reducing Patient Exposure to AerosolizedAspergillusSpecies and Other Opportunistic Molds. Clinical Infectious Diseases. 35(8). e86–e88. 60 indexed citations

19.

Fassas, Athanasios, Horace J. Spencer, Jeffrey R. Sawyer, et al.. (2002). Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma. British Journal of Haematology. 118(4). 1041–1047. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact